Mechanistic analysis demonstrated that targeting PAK1 inhibits ESCC cell growth, colony formation, anchorage-independent growth, migration, invasion and metastasis, at least in part through blocking the Raf1/MEK1/ERK signaling pathway. The gene discussed is PAK1; the disease is esophageal squamous cell carcinoma.